Catalyst Biosciences - Chart Of The Day By: TalkMarkets January 18, 2018 at 20:30 PM EST Revenue for the company previous known as Targacept is expected to grow 103.00% this year and another 125.90% next year. Read More >> Related Stocks: Catalyst Bio